4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-24-000809
President and Head of R&D acquired 863,617 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar President and Head of R&D | 2024-01-02 | Grant or award | +863,617 | 897,843 | D | ||
| Derivatives | |||||||
| Nagendran Sukumar President and Head of R&D | 2024-01-02 | Grant or award · Employee Stock Option (right to buy) | +863,617 | 863,617 | D | ||
Loading xslF345X05/doc4.xml…